Steris | STE - Cost Of Sales



Steris reported $763.1M in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
3M USD 3.65B 168M Jun/2025
Avanos Medical USD 82.9M 5.2M Jun/2025
Baxter International USD 1.82B 55M Jun/2025
Becton, Dickinson and Co. USD 2.88B 140M Jun/2025
Boston Scientific USD 1.88B 409M Jun/2025
CONMED USD 154.02M 13.93M Jun/2025
Cooper Companies USD 368.3M 45.1M Jul/2025
Dexcom USD 468.3M 21.3M Jun/2025
Ecolab USD 2.22B 160.1M Jun/2025
Edwards Lifesciences USD 344.4M 42.8M Jun/2025
Fortive USD 623.1M 29.8M Jun/2025
Getinge SEK 6.02B 1.7B Dec/2024
Globus Medical USD 278.95M 83.56M Jun/2025
Haemonetics USD 140.93M 3.38M Jun/2025
Hologic USD 447.2M 2.6M Jun/2025
Idexx Laboratories USD 414.72M 39.68M Jun/2025
Insulet USD 196.9M 36.9M Jun/2025
Integra LifeSciences USD 206.27M 38.76M Jun/2025
Intuitive Surgical USD 822.1M 26.4M Jun/2025
J&J USD 7.6B 304M Jun/2025
Masimo USD 137.6M 400K Jun/2025
Olympus JPY 71.38B 7.97B Jun/2025
Owens Minor USD 2.11B 10.27M Mar/2025
ResMed USD 541.36M 16.04M Jun/2025
Steris USD 763.1M 76.22M Jun/2025
Stryker USD 2.18B 59M Jun/2025
Tandem Diabetes Care USD 114.82M 1.19M Jun/2025
Teleflex USD 349.8M 38.57M Jun/2025
Thermo Fisher Scientific USD 6.81B 751M Jun/2025
Zimmer Biomet Holdings USD 752.8M 203M Jun/2025